Dr. Josep Dalmau received his MD and PhD from the Autonoma University of Barcelona, Spain. He trained in Neuro-oncology at Memorial Sloan-Kettering Cancer Center in New York and afterwards was appointed to the faculty. After 11 years at Memorial, he became co-director of Neuro-oncology at the University of Arkansas for Medical Sciences and in 2002 joined the University of Pennsylvania as Professor of Neurology. He is currently ICREA Research Professor at IDIBAPS-Hospital Clinic and Adjunct Professor of Neurology at Penn.
Dr. Dalmau’s early work focused on cancer-associated neuroimmunologic disorders and evolved with his discovery and characterization of autoimmune encephalitis, a new category of diseases mediated by antibodies to neuronal cell-surface and synaptic proteins. This work included uncovering the mechanisms underlying autoimmune encephalitis and the development of the first animal models of these disorders. His research has been continuously funded by agencies including the USA National Institutes of Health, the Spanish Health Institute, and the European Commission. He was elected to the National Academy of Medicine, USA and has received numerous awards including the distinguished George W. Jacoby award (American Neurological Association), the George C. Cotzias award (American Academy of Neurology), the Rey Jaime I Prize (Spain), the Editors of Brain Lecture (Association of British Neurologists), the Prize for Translational Neuroscience (Reemtsma Foundation, Max Planck Society), as well as many career awards and distinguished lectureships. He has been a highly cited researcher (Clarivate, Web of Science) since 2015. Throughout his career he has mentored numerous junior faculty, fellows, residents and graduate students who have gone on to develop successful, research careers throughout the world.